MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01357nam a22002897i 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250923101909.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250702s2015 ii a|||fr|||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9788123928814 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-GaU |
| Transcribing agency |
EG-GaU |
| Modifying agency |
EG-GaU |
| Description conventions |
rda |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
635.1 |
| Item number |
S.G.D |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Singh, Gajendra, |
| Relator term |
author. |
| 9 (RLIN) |
63211 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Drug Regulatory Affairs / |
| Statement of responsibility, etc. |
Gajendra Singh, Gaurav Agarwal & Vipul Gupta. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New Delhi : |
| Name of producer, publisher, distributor, manufacturer |
CBS Publishers & distributors Pvt Ltd, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2015 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
192 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
23 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| Content type code |
txt |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| Media type code |
n |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| Carrier type code |
nc |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
A practical guide detailing regulatory requirements governing drug development, approval, manufacturing, and monitoring. Covers regulatory bodies' roles, clinical trial regulations, pharmacovigilance, GMP standards, and global guidelines—ideal for students and professionals in pharmaceutical regulatory affairs.<br/> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug approval |
| Form subdivision |
Regulatory aspects. |
| 9 (RLIN) |
60054 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical regulation. |
| 9 (RLIN) |
60055 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Clinical trials$xLegislation & jurisprudence. |
| 9 (RLIN) |
60056 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Agarwal, Gaurav, |
| Relator term |
author. |
| 9 (RLIN) |
60053 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gupta, Vipul |
| Relator term |
author. |
| 9 (RLIN) |
60057 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |